ArticleMagnetic resonance in medicine2026
Multi-Vendor and Multi-Site Characterization of
Article in Magnetic resonance in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeDue to the inherently low signal-to-noise ratio (SNR) domain for
methodsThe proposed GRE sequence (slice selective RF pulse, slice thickness 100 mm, 16 averages, 64 × 64 matrix size, 400 × 400 mm FOV, 60 Hz/px BW, 50° FA, 80 ms TR, 14 ms TE, cartesian acquisition trajectory) was comprehensively evaluated on four clinical 3 T systems, across three sites and two vendors. Thirteen coils were evaluated, including multiple surface coils (transmit/receive and receive only) and volume coils for different body parts. The GRE sequence was compared with a previously described chemical shift imaging (CSI) technique for QC of
resultsA Passing-Bablok regression and a Spearman correlation of 0.78 demonstrated good agreement of the two methods. The GRE approach offers reduced acquisition time and simplified analysis with SNR trends demonstrating reproducible coil performance across all sites and vendors.
conclusionThis standardization aims to strengthen multi-center trials by ensuring data comparability and reliability, advancing the clinical translation of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.